AI assistant
Sending…
ABBOTT LABORATORIES — Director's Dealing 2005
Feb 23, 2005
29777_dirs_2005-02-23_f64207df-1da4-4dce-91ff-7150b78d3b42.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2005-02-18
Reporting Person: MCCULLOUGH GARY E (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2005-02-18 | Common shares without par value | A | 9300 | $46.34 | Acquired | 47329 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2005-02-18 | Option (right to buy) | $46.34 | A | 63800 | Acquired | 2015-02-17 | common shares (63800) | Direct |
Footnotes
F1: These shares represent a restricted stock award under the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The award includes the right to have stock withheld for tax purposes.
F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. The option becomes exercisable in annual increments of 21,267 on 2/18/06, 21,267 on 2/18/07 and 21,266 on 2/18/08.
More from ABBOTT LABORATORIES
Regulatory Filings
2026
Jul 16
Annual Report
2026
Jun 18
Regulatory Filings
2026
May 27
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 29
Board/Management Information
2026
Apr 27
Regulatory Filings
2026
Apr 24
Legal Proceedings Report
2026
Apr 17
Call Transcript
2026
Apr 16
Earnings Release
2026
Apr 16